Dietary l-Arginine Supplementation Enhances Endothelial Nitric Oxide Synthesis in Streptozotocin-Induced Diabetic Rats
Authors:
Open Access
- 1 March 2004
- journal article
- research article
- Published by Elsevier in The Journal of Nutrition
- Vol. 134 (3) , 600-608
Abstract
This study tested the hypothesis that dietary arginine supplementation increases endothelial tetrahydrobiopterin (BH4) availability for nitric oxide (NO) synthesis in diabetic rats. Streptozotocin-induced diabetic rats either were given unrestricted access to a casein-based diet (Expt. 1) or were pair-fed the diet on the basis of the food intake per kg of body weight of nondiabetic rats (Expt. 2). Beginning 1 d after vehicle or streptozotocin injection, arginine-HCl (1.51%) or alanine (isonitrogenous control, 2.55%) was added daily to the drinking water for nondiabetic rats, whereas concentrations were adjusted (0.43% arginine-HCl and 0.73% alanine) in the drinking water for diabetic rats (which consumed more water) to ensure isonitrogenous provision. At 2 wk after the initiation of arginine supplementation, coronary endothelial cells and plasma were obtained for the measurement of NO synthesis and metabolites. In both experiments, plasma and endothelial concentrations of NG-monomethylarginine, asymmetric dimethylarginine, and symmetric dimethylarginine increased, but those of arginine as well as endothelial BH4 availability and NO synthesis decreased in diabetic rats, compared with nondiabetic rats. In both diabetic and nondiabetic rats, arginine supplementation increased plasma concentrations of arginine and insulin, endothelial concentrations of arginine and BH4, and endothelial NO synthesis, but did not affect plasma and endothelial concentrations of methylarginines or plasma concentrations of homocysteine. Dietary arginine supplementation or provision of a BH4 precursor normalized endothelial NO synthesis in diabetic rats. Arginine supplementation did not affect plasma glucose levels in nondiabetic rats, but reduced body weight loss and plasma glucose levels in diabetic rats. Thus, dietary L-arginine supplementation stimulates endothelial NO synthesis by increasing BH4 provision, which is beneficial for vascular function and glucose homeostasis in diabetic subjects.Keywords
This publication has 51 references indexed in Scilit:
- Lack of Nitric Oxide Mediation of Flow-Dependent Arteriolar Dilation in Type I Diabetes Is Restored by SepiapterinJournal of Vascular Research, 2003
- Clarifying the Role of Insulin in Type 2 Diabetes ManagementClinical Diabetes, 2003
- Beneficial effects of L -arginine supplementation in experimental hyperlipemia-hyperglycemia in the hamsterCell and tissue research, 2002
- Endothelial dysfunction in diabetesBritish Journal of Pharmacology, 2000
- REVERSAL EFFECTS OF ? -ARGININE TREATMENT ON BLOOD PRESSURE AND VASCULAR RESPONSIVENESS OF STREPTOZOTOCIN-DIABETIC RATSPharmacological Research, 2000
- The effects of chronic L-arginine treatment on vascular responsiveness of streptozotocin-diabetic ratsGeneral Pharmacology: The Vascular System, 1999
- Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan‐induced hyperglycaemiaBritish Journal of Pharmacology, 1999
- Review of Alterations in Endothelial Nitric Oxide Production in DiabetesHypertension, 1998
- Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic RabbitsBiochemical and Biophysical Research Communications, 1996
- Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes.Journal of Clinical Investigation, 1992